Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $156.3500 (-1.89%) ($153.7100 - $160.5000) on Tue. Apr. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.39% (three month average) | RSI | 46 | Latest Price | $156.3500(-1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(40%) SPLV(31%) DIA(29%) VYM(28%) XLP(28%) | Factors Impacting ABBV price | ABBV will decline at least -0.695% in a week (0% probabilities). VIXM(-19%) UUP(-12%) TBT(-7%) UNG(-1%) VXX(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.695% (StdDev 1.39%) | Hourly BBV | -1 () | Intraday Trend | -2.5% | | | |
|
Resistance Level | $163.53 | 5 Day Moving Average | $160.86(-2.8%) | 10 Day Moving Average | $165.21(-5.36%) | 20 Day Moving Average | $163.53(-4.39%) | To recent high | -10.6% | To recent low | 18.5% | Market Cap | $275.846b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |